1. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Issue 3 (March 2020) Authors: Christenson, Eric S; Jaffee, Elizabeth; Azad, Nilofer S Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: e135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epigenetic therapy for solid tumors: from bench science to clinical trials. (April 2015) Authors: Juo, Yen-Yi; Gong, Xue-Jun; Mishra, Ankita; Cui, Xiao; Baylin, Stephen B; Azad, Nilofer S; Ahuja, Nita Journal: Epigenomics Issue: Volume 7:Number 2(2015) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study. Issue 9 (September 2021) Authors: Javle, Milind; Borad, Mitesh J; Azad, Nilofer S; Kurzrock, Razelle; Abou-Alfa, Ghassan K; George, Ben; Hainsworth, John; Meric-Bernstam, Funda; Swanton, Charles; Sweeney, Christopher J; Friedman, Claire F; Bose, Ron; Spigel, David R; Wang, Yong; Levy, Jonathan; Schulze, Katja; Cuchelkar, Vaikunth... Journal: Lancet oncology Issue: Volume 22:Issue 9(2021) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗